Ascendis Pharma A/S Announces Seven Presentations at ENDO 2021, Demonstrating Commitment to People with Rare Endocrine Diseases

NEXT STORY
Innovation Pharma’s COVID-19 Drug Candidate Brilacidin Ranked in Top Three Percent of Compounds Predicted to Be Most Effective Against SARS-CoV-2
PREV STORY
Cybrexa Therapeutics Closes $25 Million Series B Financing
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ascendis Pharma A/S Announces Seven Presentations at ENDO 2021, Demonstrating Commitment to People with Rare Endocrine Diseases

NEXT STORY
Innovation Pharma’s COVID-19 Drug Candidate Brilacidin Ranked in Top Three Percent of Compounds Predicted to Be Most Effective Against SARS-CoV-2
PREV STORY
Cybrexa Therapeutics Closes $25 Million Series B Financing
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ascendis Pharma A/S Announces Seven Presentations at ENDO 2021, Demonstrating Commitment to People with Rare Endocrine Diseases

NEXT STORY
Innovation Pharma’s COVID-19 Drug Candidate Brilacidin Ranked in Top Three Percent of Compounds Predicted to Be Most Effective Against SARS-CoV-2
PREV STORY
Cybrexa Therapeutics Closes $25 Million Series B Financing
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Acer Therapeutics Reports First Quarter 2018 Financial Results and Provides Corporate Update

Acer continues progression from development to potential commercialization of EDSIVO™ Company appoints Chief Legal ...

author_avatar
NASDAQ Market News

Argos Therapeutics Announces Interim Analysis of Phase 3 ADAPT Trial to be Presented at ESMO 2017 Congress

DURHAM, N.C., Aug. 21, 2017 (GLOBE NEWSWIRE) -- Argos Therapeutics Inc. (NASDAQ:ARGS), an immuno-oncology ...

author_avatar
NASDAQ Market News

Immuron Appoints Gary S. Jacob, Ph.D., Experienced US Based Biotechnology Executive, as CEO

MELBOURNE, Australia, Nov. 19, 2018 (GLOBE NEWSWIRE) -- Immuron Limited, (IMC or the Company), ...

author_avatar
NASDAQ Market News